Literature DB >> 13485042

Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.

R H WAGNER, R D LANGDELL, B A RICHARDSON, R A FARRELL, K M BRINKHOUS.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; HEMOPHILIA/blood in

Mesh：

Substances：

Year:  1957        PMID： 13485042     DOI： 10.3181/00379727-96-23417

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  4 in total

1.  The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans.

Authors:  E ADELSON; J J RHEINGOLD; O PARKER; M STEINER; J C KIRBY
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

2.  The value of animal models.

Authors:  T C Jones
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

Review 3.  Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B.

Authors:  T C Nichols; R A Raymer; H W G Franck; E P Merricks; D A Bellinger; N DeFriess; P Margaritis; V R Arruda; M A Kay; K A High
Journal:  Haemophilia       Date:  2010-05       Impact factor: 4.287

Review 4.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.